Soboslay P T, Lüder C G, Hoffmann W H, Michaelis I, Helling G, Heuschkel C, Dreweck C M, Blanke C H, Pritze S, Banla M
Institute of Tropical Medicine, University of Tübingen, Germany.
Clin Exp Immunol. 1994 May;96(2):238-44. doi: 10.1111/j.1365-2249.1994.tb06548.x.
The present study examined the quantitative and qualitative changes registered in the parasite-specific antibody response, cellular reactivity and cytokine production profile in onchocerciasis patients repeatedly treated with ivermectin over a period of 8 years. The densities of Onchocerca volvulus microfilariae (mf) in treated patients remained significantly reduced, whereas the number of permanently amicrofilaridermic patients (subclinical infection) increased with repeated treatments. In vitro cellular responses to O. volvulus antigen (OvAg) were highest (P < 0.01) in untreated control individuals exposed to infection, but negative for mf of O. volvulus (endemic normals). Cellular reactivity in repeatedly treated patients was higher at 84 than at 36 months post initial treatment (p.i.t); furthermore, the proliferative responses to OvAg, mycobacterial purified protein derivative (PPD) and streptococcal SL-O were greater (P < 0.05) at 84 months p.i.t. in amicrofilaridermic than in microfilaria-positive onchocerciasis patients. In amicrofilaridermic patients such reactivity approached the magnitude observed in endemic normals. Peripheral blood mononuclear cells (PBMC) from patients and endemic normals produced equivalent amounts of IL-2, IL-4 and interferon-gamma (IFN-gamma) in response to mitogenic stimulation with phytohaemagglutinin (PHA); in response to OvAg, however, significantly more IL-2 and IFN-gamma were produced by PBMC from subclinical amicrofilaridermic patients or endemic normals than by mf-positive patients. OvAg-specific production of IL-4 by PBMC from treated patients was lower at 84 than at 36 months p.i.t. At three months p.i.t. the titres of circulating OvAg-specific IgG1-3 had increased (P < 0.05), but they then continuously declined with repeated treatments. Only IgG1 and IgG4 bound to OvAg of mol. wt 2-12 kD at 1 month p.i.t., while recognition of OvAg of mol. wt 10-200 kD by IgG1, IgG2 and IgG4 reached a maximum intensity at 3-6 months p.i.t., with the overall intensity of binding to OvAg gradually weakening thereafter. These results suggest that onchocerciasis-associated immunosuppression is reversible following ivermectin-induced permanent clearance of microfilariae from the skin; and that a vigorous parasite-specific cellular reactivity and a sustained production of IL-2 and IFN-gamma in amicrofilaridermic individuals may contribute to controlling O. volvulus infection.
本研究检测了盘尾丝虫病患者在8年期间反复接受伊维菌素治疗后,寄生虫特异性抗体反应、细胞反应性和细胞因子产生谱的定量和定性变化。接受治疗患者体内的旋盘尾丝虫微丝蚴(mf)密度仍显著降低,而永久性无微丝蚴血症患者(亚临床感染)的数量随着反复治疗而增加。未接受治疗的感染对照个体对旋盘尾丝虫抗原(OvAg)的体外细胞反应最高(P<0.01),但对旋盘尾丝虫mf呈阴性反应(地方性正常人群)。反复治疗患者在初始治疗后84个月时的细胞反应性高于36个月时(p.i.t);此外,在初始治疗后84个月时,无微丝蚴血症患者对OvAg、结核分枝杆菌纯化蛋白衍生物(PPD)和链球菌SL-O的增殖反应大于微丝蚴阳性的盘尾丝虫病患者(P<0.05)。在无微丝蚴血症患者中,这种反应性接近地方性正常人群中观察到的水平。患者和地方性正常人群的外周血单个核细胞(PBMC)在受到植物血凝素(PHA)促有丝分裂刺激后产生等量的白细胞介素-2(IL-2)、IL-4和干扰素-γ(IFN-γ);然而,在受到OvAg刺激后,亚临床无微丝蚴血症患者或地方性正常人群的PBMC产生的IL-2和IFN-γ明显多于微丝蚴阳性患者。接受治疗患者的PBMC在初始治疗后84个月时对OvAg特异性产生的IL-4低于36个月时。在初始治疗后3个月时,循环中OvAg特异性IgG1-3的滴度升高(P<0.05),但随后随着反复治疗而持续下降。在初始治疗后1个月时,只有IgG1和IgG4与分子量为2-12 kD的OvAg结合,而IgG1、IgG2和IgG4对分子量为10-200 kD的OvAg的识别在初始治疗后3-6个月时达到最大强度,此后与OvAg结合的总体强度逐渐减弱。这些结果表明,伊维菌素诱导皮肤中微丝蚴永久性清除后,盘尾丝虫病相关的免疫抑制是可逆的;并且在无微丝蚴血症个体中强烈的寄生虫特异性细胞反应性以及IL-2和IFN-γ的持续产生可能有助于控制旋盘尾丝虫感染。